Catherine Tinsley comments on why the risk of contracting coronavirus is not enough to keep people apart in Fox News Feature
March 26th, 2020
Now more than ever before, not only medical issues but also economic and social issues influence how health care is organized, governed, financed, and delivered.
Our empirical research advances understanding of the economics and regulation of the health care industry, with an emphasis on the biopharmaceutical and medical device industries. Faculty researchers examine a variety of issues, most typically around firm, industry, and regulatory organization and performance. Past and ongoing research includes the speed of drug development, sales and promotion strategies during adverse regulatory events, regulatory compliance, health care payment reform, and the effect of eHealth on health behaviors and outcomes. Some research projects entail the development and analysis of proprietary data, while others are conducted in collaboration with the U.S. Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC).
Principal Investigator and Convener: Jeffrey Macher
Health Leaders Media reported on Center Scholar Yunan Ji’s study on hospital characteristics associated with price transparency compliance
June 29, 2022
The Daily Mail reported on the problem with sponsored research in assigning the ‘healthy foods’ label citing Center Scholar Anita Rao’s study
July 4, 2022
Forbes’ article entitled ‘Why Companies Should Try Harder To Prevent Product Recalls’ cited the research of the Center’s Jeffrey Macher on the effect of product recalls on innovation
March 7, 2019